Pyxis Oncology Inc (PYXS) Stock: What Does the Chart Say Wednesday?

Overall market sentiment has been neutral on Pyxis Oncology Inc (PYXS) stock lately. PYXS receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator.

Pyxis Oncology Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on PYXS!

See Full PYXS Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With PYXS Stock Today?

Pyxis Oncology Inc (PYXS) stock is trading at $4.16 as of 2:09 PM on Wednesday, Mar 27, a rise of $0.33, or 8.49% from the previous closing price of $3.83. The stock has traded between $3.78 and $4.29 so far today. Volume today is light. So far 639,192 shares have traded compared to average volume of 911,225 shares.

More About Pyxis Oncology Inc

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Click Here to get the full Stock Report for Pyxis Oncology Inc stock.